Partnering with a US-based CDMO can offer several advantages to pharmaceutical companies seeking the US market.[1][2] A CDMO effectively manages labor, materials, operations, and quality, resulting in better cost control.[1] It provides access to high-quality manufacturing facilities, thereby reducing overall production costs and increasing flexibility in adapting to changes in product demand.[1][2] Experienced project management includes a dedicated manager and on-site staff to handle unexpected challenges and ensure smooth production.[1] The partnership enables the scaling of production without large investments in infrastructure, technology or personnel.[2][5] It provides end-to-end support from development to commercial production, reducing time to market and minimizing technology transfer risks.[3][4][7] CDMO brings access to advanced technologies and adherence to high quality standards and regulations.[4][5]